Pulmonary Rehabilitation Awareness Week Day 1 🫁 Only 36.9% of eligible patients are referred to PR. An introduction to our service for patients & referrers: youtu.be/B5Rr14IdQvk?si… Share far & wide 💙 Pulmonary Rehab Awareness National Respiratory Audit Programme Mid Yorkshire Teaching NHS Trust ACPRC Action for Pulmonary Fibrosis Asthma + Lung UK

Have you explored pulmonary rehabilitation options in your local area?

What is your opinion regarding genetic testing for pulmonary fibrosis/ILD? #pulmonaryfibrosis #ILD (comment below if 'Other')

Lots of companies, both large and small, as well as most large universities around the world are working on treatments for #ILD and pulmonary fibrosis. It's actually fascinating to see this work happening, how people from all over the world meet and work together to discuss the

54 - Is a CT scan necessary to detect Pulmonary Fibrosis? youtu.be/8aesObW1RFA An overview of why a chest CT scan is required in most cases of interstitial lung disease / pulmonary fibrosis. The CT scan is a radiological investigation which offers a 3D picture of the lung

If you are a Respiratory doctor / pulmonologist - Do you routinely ask your patients with ILD/pulmonary fibrosis about their family history?

If you're a patient suffering from a RARE lung condition would you agree to share details about your condition to help research? And under which circumstances? (Pls comment if 'Other'). Context: it is often very difficult for researchers to find suitable data to study rare

September 2024 is #pulmonaryfibrosis awareness month!

Rare, but not "rare" ! Limited awareness of Interstitial Lung Diseases (ILDs) likely leads to MANY missed diagnoses. Sept 24 is #pulmonaryfibrosis #awareness month!

So much more to learn about progressive pulmonary fibrosis

What's the most confusing thing for you regarding pulmonary fibrosis/ ILD?

Patient engagement is essential for meaningful #ILD research

Good summary slide on current understanding of pathogenic genomic variants in familial #pulmonaryfibrosis - the problem is that we need to do more testing to better understand what is pathogenic (i.e. causing disease) vs. benign (i.e. normal genetic differences)

Wonderful project presented by the #ILD specialist nursing team in Manchester, who have so much experience to share regarding real-life management of pulmonary fibrosis. Great team (!) and happy to see their work showcased at the #ERSCongress